Associated Company
Omondi Healthcare Limited is an associated company under the control of the director Dr Edmond Edi-Osagie holds 775 10p Ordinary Shares there being 1000 10p Ordinary Shares in issue.
Dr Edmond Edi-Osagie is a director of Omondi Healthcare Limited.
Charges totalling £28,224 (2024 £37,100) were made by ProFertil (UK) Limited for surgical support and assistance and are included in turnover. The Directors report that charges were set in accordance with open market rates.
Profertil (UK) Limited ceased to trade on 29 May 2025. At this point any remaining tangible fixed assets were taken over by Omondi Healthcare Limited for a consideration of £1,500.
At the same time intangible fixed assets were deemed by the director to have no value and have been written off.
Transactions in the year with Omondi Healthcare Limited were then as follows:
Balance due to Omondi Healthcare Limited brought forward (£22,280) (2024 (£24,280))
Monies received from Omondi Healthcare Limited in the period £22,480 (2024 £39,100)
Charges made by ProFertil (UK) Limited for medical services £28,224 (2024 £37,100)
Consideration for takeover of tangible fixed assets £1,500 (2024 £Nil)
Balance due to/(from) Omondi Healthcare Limited carried forward (£29,524) (2024 (£22,280))